SCHEMBL17467147

SCHEMBL17467147

COc1ccc(Br)nc1N(C)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAX8 Q06710 1/20 0.37
AAK1 Q2M2I8 1/20 0.34
MTNR1A P48039 3/20 0.33
MTNR1B P49286 3/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 3/20 0.33
BACE1 P56817 1/20 0.32
ITGA4 P13612 1/20 0.32
ITGB7 P26010 1/20 0.32
POLB P06746 2/20 0.32
GAA P10253 1/20 0.32
TTK P33981 1/20 0.32
PKM P14618 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SSTR4 P31391 1/20 0.32
MEN1 O00255 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NCEH1 Q6PIU2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17467122 0.87 BACE1 (0.37) PAX8AAK1MTNR1AMTNR1BKDM4E
SCHEMBL8234275 0.84 PAX8 (0.38) PAX8MTNR1AMTNR1BKDM4EALDH1A1
SCHEMBL15587576 0.83 PAX8 (0.37) PAX8AAK1MTNR1AMTNR1BKDM4E
SCHEMBL15545096 0.81 KDM4E (0.39) KDM4EALDH1A1POLBL3MBTL1MEN1
SCHEMBL4070313 0.79 ALDH1A1 (0.40) PAX8MTNR1AMTNR1BKDM4EALDH1A1
SCHEMBL8226698 0.79 MTNR1A (0.35) PAX8AAK1MTNR1AMTNR1BKDM4E
SCHEMBL17467163 0.79 PAX8 (0.38) PAX8AAK1BACE1POLBTTK
SCHEMBL8236816 0.75 KMT2A (0.40) MTNR1AMTNR1BKDM4EALDH1A1POLB
SCHEMBL4064565 0.75 PAX8 (0.34) PAX8MTNR1AMTNR1BKDM4EITGA4
SCHEMBL17467171 0.74 L3MBTL1 (0.36) KDM4EALDH1A1L3MBTL1MEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9249160-B2 Orexin receptor antagonists HEPTARES THERAPEUTICS LIMITED (GB) 2016-02-02 US disclosed